The investigators will conduct a randomized controlled trial (RCT) to examine how an online training and peer support platform could help the preparation to transition to adult care. Among 14-16 year old youth with Type 1 Diabetes (T1D), the investigators aim to assess the effect of an online training and peer support platform (Support-t) integrated in usual care, compared with usual care on Hemoglobin A1c (HbA1c), adverse outcomes and psychosocial measures during the preparation for transition to adult care. The investigators will conduct a multi-site, parallel group, blinded (outcome assessors, data analysts), superiority RCT of adolescents with T1D (14-16 years of age) followed at one of 4 university teaching hospital-based pediatric diabetes clinics in the province of Quebec.
Adolescents with a clinical diagnosis of T1D
14-16 years of age
Receiving diabetes care at one of 4 university teaching hospital-based pediatric diabetes clinics in Quebec: Montreal Children's Hospital-McGill University Health Centre, Centre hospitalier universitaire de Sherbrooke, Le Copain-Hôpital de Gatineau, Centre Hospitalier Universitaire de Québec
Having access to internet
Severe neurocognitive disabilities
Patients with conditions associated with shortened erythrocyte survival, such as hemolytic anemia or other conditions associated with inaccurate HbA1c
Parallel
Support-t
Other interventionSupport-t plus usual diabetes care for 18 months
Change from Baseline Hemaglobin A1c (HbA1c) at 18 months
HbA1c measured with a venous or capillary blood sample as part of the standard of diabetes care will be derived from the medical record chart or measured using an A1c Test Kit, which is a non-fasting, finger prick, whole blood test
Change from Baseline Hemaglobin A1c (HbA1c) at 6 and 12 months
HbA1c measured with a venous or capillary blood sample as part of the standard of diabetes care will be derived from the medical record chart or measured using an A1c Test Kit, which is a non-fasting, finger prick, whole blood test
Continuous Glucose Monitoring (CGM) - % Time in range
% Time in range (3.9-10.0mmol/L) over the past 4 weeks will be derived from the medical record chart
Continuous Glucose Monitoring (CGM) - % Time above range
% Time above range (3.9-10.0mmol/L) over the past 4 weeks will be derived from the medical record chart
Continuous Glucose Monitoring (CGM) - % Time below range
% Time below range (3.9-10.0mmol/L) over the past 4 weeks will be derived from the medical record chart
Engagement with Support-t platform (T1D patient) - time in minutes on platform
Engagement metrics will be extracted using Google analytics - time (minutes) spent on the platform
Engagement with Support-t platform (T1D patient) - discussion forum participation
Engagement metrics will be extracted using Google analytics - participation on the platform discussion forum
Engagement with Support-t platform (T1D patient) - content accessed
Engagement metrics will be extracted using Google analytics - specific content accessed from the platform
Engagement with Support-t platform (T1D patient) - total pages viewed
Engagement metrics will be extracted using Google analytics - total pages viewed from the platform
Click on the lead sponsor to view all of their trials.
Anne-Sophie Brazeau
Lead sponsor
McGill University
Sponsor institution
McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborator
CSSS de Gatineau
Collaborator
Centre de recherche du CHU de Sherbrooke
Collaborator
CHU de Quebec-Universite Laval
Collaborator
